Skip to main content

Find Clinical Trials

Home
Conditions
Hypoparathyroidism

Clinical trial condition

Hypoparathyroidism

Explore clinical trials studying Hypoparathyroidism. Study availability and eligibility vary by location and protocol.

70 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Hypoparathyroidism trial results

Completed

Evaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY)

NCT04059380

Conditions: Calcium Metabolism Disorders, Endocrine System Diseases, Hypocalcemia, +11 more
Locations: Department of Experimental Medicine, "Sapienza" University of Rome Rome, Italy

View Trial Details

Completed

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

NCT04750460

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Saint-Petersburg State University Hospital Saint Petersburg, Russia

View Trial Details

Completed

Parathyroid and Thymus Transplantation in DiGeorge #931

NCT00566488

Conditions: 22q11 Deletion Syndrome, Abnormalities, Multiple, Cardiovascular Abnormalities, +19 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

QoL and Cognitive Function in Patients With Hypoparathyroidism

NCT04569604

Conditions: Bone Diseases, Bone Diseases, Metabolic, Calcium Metabolism Disorders, +16 more
Locations: Clinic for Osteoporosis, Aarhus University Hospital Aarhus N, Jutland, Denmark

View Trial Details

Completed

A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism

NCT02910466

Conditions: Chronic Hypoparathyroidism, Endocrine System Diseases, Hypoparathyroidism, +1 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Completed

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

NCT01268098

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Advance Medical Research LLC Lakewood, California, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University School of Medicine Indianapolis, Indiana, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary

NCT01455181

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Semmelweis University Medical School Budapest, Hungary

University of Pécs, School of Medicine Pécs, Hungary

University of Szeged Szeged, Hungary

View Trial Details

Completed

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

NCT03150108

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Glendale Adventist Medical Center Glendale, California, United States

View Trial Details

Completed

Use of NPSP558 in the Treatment of Hypoparathyroidism

NCT00732615

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Mayo Clinic-Scottsdale Scottsdale, Arizona, United States

Advance Medical Research LLC Lakewood, California, United States

Diabetes Associates Orange, California, United States

University of California-San Francisco VA Medical Center San Francisco, California, United States

View all 31 locations

View Trial Details

Completed

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

NCT01297309

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Advance Medical Research LLC Lakewood, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University School of Medicine Indianapolis, Indiana, United States

View all 14 locations

View Trial Details